Benjamin J Cowling1, Peng Wu1, Janice Y C Lo2, Kwok-Hung Chan3, Eunice L Y Chan4, Vicky J Fang1, Lok-Yee So5, J S Malik Peiris1,6, Susan S Chiu4. 1. World Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, University of Hong Kong. 2. Public Health Laboratory Services Branch, Centre for Health Protection, Hong Kong Department of Health. 3. Microbiology. 4. Pediatrics and Adolescent Medicine, University of Hong Kong. 5. Department of Pediatrics and Adolescent Medicine, Pamela Youde Nethersole Eastern Hospital. 6. Centre of Influenza Research, School of Public Health, University of Hong Kong, Hong Kong Special Administration Region, China.
Abstract
BACKGROUND: Influenza B virus has been perceived to cause less disease burden and milder disease compared with influenza A, but recent studies suggest that influenza B does have a significant impact. We aimed to estimate the burden of influenza B virus infections on hospitalizations in Hong Kong, in the context of virus lineage changes over time. METHODS: The pediatric age-specific rates of influenza B hospitalization in Hong Kong for 2004-2014 were estimated based on admissions to 2 hospitals that together catered for 72.5% of all pediatric admissions on Hong Kong Island. Influenza B virus was detected by immunofluorescence and culture on nasopharyngeal aspirates. Lineage typing was performed by real-time reverse-transcription polymerase chain reaction. RESULTS: A total of 5085 children were recruited on 1 designated day each week, year-round during the 11 years, and 221 (4.3%) tested positive for influenza B. Hospitalization rates were highest in children aged 2 to <5 years with year-to-year variation. Victoria-lineage viruses appeared to be associated with a greater fraction of influenza B hospitalizations in children than of influenza B infections in the general community. Influenza B did not cause significant hospitalization in infants <1 year of age. CONCLUSIONS: We report one of the first population-based, age- and lineage-specific studies of pediatric hospitalization for influenza B. We found that changes in lineage were associated with higher hospitalization rates and documented that Victoria lineage viruses were associated with greater pediatric hospitalization burden compared with Yamagata lineage viruses.
BACKGROUND: Influenza B virus has been perceived to cause less disease burden and milder disease compared with influenza A, but recent studies suggest that influenza B does have a significant impact. We aimed to estimate the burden of influenza B virus infections on hospitalizations in Hong Kong, in the context of virus lineage changes over time. METHODS: The pediatric age-specific rates of influenza B hospitalization in Hong Kong for 2004-2014 were estimated based on admissions to 2 hospitals that together catered for 72.5% of all pediatric admissions on Hong Kong Island. Influenza B virus was detected by immunofluorescence and culture on nasopharyngeal aspirates. Lineage typing was performed by real-time reverse-transcription polymerase chain reaction. RESULTS: A total of 5085 children were recruited on 1 designated day each week, year-round during the 11 years, and 221 (4.3%) tested positive for influenza B. Hospitalization rates were highest in children aged 2 to <5 years with year-to-year variation. Victoria-lineage viruses appeared to be associated with a greater fraction of influenza B hospitalizations in children than of influenza B infections in the general community. Influenza B did not cause significant hospitalization in infants <1 year of age. CONCLUSIONS: We report one of the first population-based, age- and lineage-specific studies of pediatric hospitalization for influenza B. We found that changes in lineage were associated with higher hospitalization rates and documented that Victoria lineage viruses were associated with greater pediatric hospitalization burden compared with Yamagata lineage viruses.
Authors: W Paul Glezen; Jordana K Schmier; Carrie M Kuehn; Kellie J Ryan; John Oxford Journal: Am J Public Health Date: 2013-01-17 Impact factor: 9.308
Authors: Carol Yuet Sheung Yuen; Daniel Yee Tak Fong; Irene Lai Yin Lee; Sing Chu; Esther Sau-mei Siu; Marie Tarrant Journal: Vaccine Date: 2013-09-07 Impact factor: 3.641
Authors: Susan S Chiu; Shuo Feng; Kwok-Hung Chan; Janice Y C Lo; Eunice L Y Chan; Lok-Yee So; Benjamin J Cowling; J S Malik Peiris Journal: Vaccine Date: 2016-03-21 Impact factor: 3.641
Authors: K H Chan; N Maldeis; W Pope; A Yup; A Ozinskas; J Gill; W H Seto; K F Shortridge; J S M Peiris Journal: J Clin Microbiol Date: 2002-05 Impact factor: 5.948
Authors: B Zhao; S Qin; Z Teng; J Chen; X Yu; Y Gao; J Shen; X Cui; M Zeng; X Zhang Journal: Clin Microbiol Infect Date: 2015-04-13 Impact factor: 8.067
Authors: Benjamin J Cowling; Celine S L Chui; Wey Wen Lim; Peng Wu; Christopher K M Hui; J S Malik Peiris; Esther W Chan Journal: PLoS One Date: 2018-01-19 Impact factor: 3.240
Authors: Danuta M Skowronski; Catharine Chambers; Gaston De Serres; Suzana Sabaiduc; Anne-Luise Winter; James A Dickinson; Jonathan B Gubbay; Kevin Fonseca; Steven J Drews; Hugues Charest; Christine Martineau; Mel Krajden; Martin Petric; Nathalie Bastien; Yan Li Journal: J Infect Dis Date: 2017-09-15 Impact factor: 5.226
Authors: Susan S Chiu; Benjamin J Cowling; J S Malik Peiris; Eunice L Y Chan; Wilfred H S Wong; Kwok Piu Lee Journal: Emerg Infect Dis Date: 2022-01 Impact factor: 6.883
Authors: Gideon O Emukule; Fredrick Otiato; Bryan O Nyawanda; Nancy A Otieno; Caroline A Ochieng; Linus K Ndegwa; Peter Muturi; Godfrey Bigogo; Jennifer R Verani; Philip M Muthoka; Elizabeth Hunsperger; Sandra S Chaves Journal: Open Forum Infect Dis Date: 2019-09-30 Impact factor: 3.835
Authors: Danuta M Skowronski; Macy Zou; Suzana Sabaiduc; Michelle Murti; Romy Olsha; James A Dickinson; Jonathan B Gubbay; Matthew A Croxen; Hugues Charest; Agatha Jassem; Mel Krajden; Nathalie Bastien; Yan Li; Gaston De Serres Journal: Euro Surveill Date: 2020-02